Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves’ disease patients and in healthy individuals

References

• Davies, P., and T. Larsen . 2007. Thyrotoxicosis. In Williams Textbook of Endocrinology , 11th ed. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen , eds. Saunders, Philadelphia, PA. p. 333–376
   Google Scholar
• Weetman, A. P., and A. M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15: 788–830
   PubMed Web of Science ®Google Scholar
• Tomer, Y., and A. Huber . 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32: 231–239
   PubMed Web of Science ®Google Scholar
• Tomer, Y., A. Greenberg, G. Barbesino, et al. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. JCEM. 86: 1687–1693
   PubMed Web of Science ®Google Scholar
• Ueda, H., J. M. M. Howson, L. Esposito, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423: 506–511
   PubMed Web of Science ®Google Scholar
• Kieff, E. D., and A. B. Rickinson . 2006. Epstein–Barr virus and its replication. In Fields Virology , 5th ed. D. M. Knipe and P. M. Howley , eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2603–2654
   Google Scholar
• Rickinson, A. B., and E. Kieff . 2006. Epstein–Barr virus. In Fields Virology , 5th ed. D. M. Knipe and P. M. Howley , eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2655–2700
   Google Scholar
• Sutton, R. N. P., R. T. D. Emond, D. B. Thomas, and D. Doniach . 1974. The occurrence of autoantibodies in infectious mononucleosis. Clin. Exp. Immunol. 17: 427–436
   PubMed Web of Science ®Google Scholar
• Whittingham, S., J. McNeilage, and I. R. Mackay . 1985. Primary Sjögren's syndrome after infectious mononucleosis. Ann. Intern. Med. 102: 490–493
   PubMed Web of Science ®Google Scholar
• James, J. A., K. M. Kaufman, A. D. Farris, et al. 1997. An increased prevalence of Epstein–Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100: 3019–3026
   PubMed Web of Science ®Google Scholar
• Nagata, K., S. Fukata, K. Kanai, et al. 2011. The influence of Epstein–Barr virus reactivation in patients with Graves’ disease. Viral Immunol. 24: 143–149
   PubMed Web of Science ®Google Scholar
• Crawford, D. H., and I. Ando . 1986. EB virus induction is associated with B-cell maturation. Immunology. 59: 405–409
   PubMed Web of Science ®Google Scholar
• Laichalk, L. L., and D. A. Thorley-Lawson . 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein–Barr virus in vivo. J. Virol. 79: 1296–1307
   PubMed Web of Science ®Google Scholar
• Kimura, H., K. Miyake, Y. Yamauchi, et al. 2009. Identification of Epstein–Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative disease. J. Infect. Dis. 200: 1073–1087
   Web of Science ®Google Scholar
• Rees Smith, B., and R. Hall . 1974. Thyroid-stimulating immunoglobulins in Graves’ disease. Lancet. 2: 427–431
   PubMed Web of Science ®Google Scholar
• Michelangeli, V., C. Poon, J. Taft, et al. 1998. The prognostic value of thyrotropin receptor antibody measurement in early stages of treatment of Graves’ disease with antithyroid drugs. Thyroid. 8: 119–124
   PubMed Web of Science ®Google Scholar
• Costagliola, S., N. G. Morgenthaler, R. Hoermann, et al. 1999. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease. JCEM. 84: 90–97
   PubMed Web of Science ®Google Scholar
• Frisan, T., V. Levitsky, and M. Masucci . 2001. Generation of lymphoblastoid cell lone (LCLs). In Epstein–Barr Virus Protocols (Method in Molecular Biology Vol. 174). J. Wilson and G. H. W. May , eds. Humana Press, Totowa. p. 125–127
   Google Scholar
• Nilsson, K. 1971. High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int. J. Cancer. 8: 432–442
   PubMed Web of Science ®Google Scholar
• Tanaka, K., G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport . 1999. Subunit structure of thyrotropin receptors expressed on the cell surface. J. Biol. Chem. 274: 33979–33984
   PubMed Web of Science ®Google Scholar
• Oda, Y., J. Sauders, S. Roberts, et al. 1999. Analysis of carbohydrate residues on recombinant human thyrotropin receptor. JCEM. 84: 2119–2125
   PubMed Web of Science ®Google Scholar
• Roederer, M. 2001. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194–205
   PubMedGoogle Scholar
• Perfetto, S. P., P. K. Chattopadhyay, and M. Roederer . 2004. Seventeen-color flow cytometry: unraveling the immune system. Nat. Rev. Immunol. 4: 648–655
   PubMed Web of Science ®Google Scholar
• Fan, J. L., R. K. Desai, J. S. Dallas, et al. 1994. High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves’ disease. Clin. Immunol. Immunopathol. 71: 69–74
   PubMedGoogle Scholar
• Henle, W., G. Kohn, H. zur Hauzen, and G. Henle . 1967. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 157: 1064–1065
   PubMed Web of Science ®Google Scholar
• Nilsson, K., G. Klein, W. Henle, and G. Henle . 1971. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int. J. Cancer. 8: 443–450
   PubMed Web of Science ®Google Scholar
• Fox, R. I., M. Luppi, H. I. Kang, and P. Pisa . 1991. Reactivation of Epstein–Barr virus in Sjögren's syndrome. Springer Semin. Immunopathol. 13: 217–231
   PubMed Web of Science ®Google Scholar
• Nagata, Y., H. Inoue, K. Yamada, et al. 2004. Activation of Epstein–Barr virus by saliva from Sjögren's syndrome patients. Immunology 111: 223–229
   PubMed Web of Science ®Google Scholar
• Nagoya, T., and Hinuma, Y. 1972. Production of infective Epstein–Barr virus in a Burkitt lymphoma cell line, P3HR-1. GANN. 63: 87–93
   PubMedGoogle Scholar
• Sairenji, T., G. Bertoni, M. M. Medveczky, et al. 1988. Inhibition of Epstein–Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J. Virol. 62: 2614–2621
   PubMed Web of Science ®Google Scholar
• Casali P., M. Nakamura, F. Ginsberg-Fellner, and A. L. Notkins . 1990. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J. Immunol. 144: 3741–3747
   PubMed Web of Science ®Google Scholar
• Nakamura M., S. E. Burastero, Y. Ueki, et al. 1988. Probing the normal and autoimmune B cell repertoire with Epstein–Barr virus. J. Immunol. 141: 4165–4172
   PubMed Web of Science ®Google Scholar